Nn9535-4984
Research payments
$2,783,366
Through program year 2025, $2,783,366 in research payments was reported against Nn9535-4984, across 14,105 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $145,478 | 31 |
| 2024 | Research | $277,997 | 106 |
| 2023 | Research | $1,802,169 | 2,883 |
| 2022 | Research | $557,722 | 11,085 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Turner Meridian, ID Named on 954 payments
- Ildiko Lingvay Dallas, TX Named on 742 payments
- Robert Busch Albany, NY Named on 708 payments
- John Buse Chapel Hill, NC Named on 629 payments
- Michael Lillestol Fargo, ND Named on 416 payments
- Ramon Ortiz Carrasquillo Manati, PR Named on 359 payments
- Lisa Usdan Memphis, TN Named on 353 payments
- J. Evans Jacksonville, FL Named on 350 payments
- Julio Rosenstock Dallas, TX Named on 321 payments
- Emily Morawski Kingsport, TN Named on 310 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.